C-arm manufacturer OEC Medical Systems reported strong third-quarter (end-September) results this month. The company posted revenues of $47.9 million, an increase of 23% over $39 million in sales for the same period last year. The quarter’s net
C-arm manufacturer OEC Medical Systems reported strong third-quarter (end-September) results this month. The company posted revenues of $47.9 million, an increase of 23% over $39 million in sales for the same period last year. The quarters net income climbed 25%, from $3.4 million to $4.3 million.
Executives with the Salt Lake City firm attributed the strong product demand to the increase in minimally invasive procedures, as well as increasing use by healthcare delivery networks of outpatient procedures.
In other OEC news, the company announced Oct. 16 that Dallas-based supply chain management company Novation awarded OEC a three-year contract, making OEC Novations sole-source supplier of mobile C-arms. The deal is estimated at approximately $30 million annually. It includes OECs Mini 6600 C-arm and its full-size mobile units Series 9600, 7600, and 7700. The OEC award is Novations first capital equipment contract as a new entity, according to OEC.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.